Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-45040
Parasitol Int 2017 Apr 01;662:47-55. doi: 10.1016/j.parint.2016.11.010.
Show Gene links Show Anatomy links

Antiproliferative and ultrastructural effects of phenethylamine derivatives on promastigotes and amastigotes of Leishmania (Leishmania) infantum chagasi.

Brasil PF , de Freitas JA , Barreto ALS , Adade CM , Reis de Sá LF , Constantino-Teles P , Toledo FT , de Sousa BA , Gonçalves AC , Romanos MTV , Comasseto JV , Dos Santos AA , Tessis AC , Souto-Padrón T , Soares RMA , Ferreira-Pereira A .


???displayArticle.abstract???
Leishmania (Leishmania) infantum chagasi is one of the agents that cause visceral leishmaniasis. This disease occurs more frequently in third world countries, such as Brazil. The treatment is arduous, and is dependent on just a few drugs like the antimonial derivatives and amphotericin B. Moreover, these drugs are not only expensive, but they can also cause severe side effects and require long-term treatment. Therefore, it is very important to find new compounds that are effective against leishmaniasis. In the present work we evaluated a new group of synthetic amides against the promastigote and amastigote forms of L. infantum chagasi. The results showed that one of these amides in particular, presented very effective activity against the promastigotes and amastigotes of L. infantum chagasi at low concentrations and it also presented low toxicity for mammal cells, which makes this synthetic amide a promising drug for combating leishmaniasis.

???displayArticle.pubmedLink??? 27888011
???displayArticle.link??? Parasitol Int